> dubious mRNA treatments with unknown compounding risks for unknown numbers of people
If that was the case, after 100s of millions of doses given out shouldn’t these have surfaced in sufficient numbers?
Sorry about your condition, but there’s nothing there that suggests it is related to the mRNA formulation; you could just as easily experienced the same with a viral vector formulation or even without any booster (long covid, if that’s what you had, is not without relapses)
Development corners were not cut, that’s the point of the mRNA formulation, it is incredibly faster than conventional methods to create a brand new product. I assume what you meant was the regulatory requirements for safety, which yes were accelerated and reduced because of the emergency use case. Two years ago. Those trials are tests on large populations , phase 3 being the largest then phase 4 a post-marketing surveillance period [0].
[0] https://en.m.wikipedia.org/wiki/Phases_of_clinical_research